Study Finds No Link Between Smoking Cannabis and Cognitive Decline
Recent research on cannabis use and cognitive decline found no significant association in aging populations. This challenges previous assumptions about cannabis's neurotoxic effects. Clinicians can use this evidence to counsel patients more accurately…
Machine Learning Models Identify Key Predictors of Driving Under the Influence
Machine learning impaired driving risk models help identify key predictors of driving under the influence of alcohol or cannabis. These models enable clinicians to better assess patient risk and provide targeted counseling. Understanding these predictors…
Does Cannabis Use by Older Adults Accelerate Mental Decline? | Trending – Labroots
This article reviews cannabis use older adults mental decline and recent findings on cognitive safety. Evidence suggests no direct link between cannabis and accelerated mental decline in older adults. Clinicians should still assess individual risks and…
Valsartan’s Role in Modulating Neuroinflammation via Endocannabinoid System
This study highlights endocannabinoid system modulation as a key mechanism by which valsartan mitigates neuroinflammation. Valsartan may reduce lipopolysaccharide-induced cognitive deficits through this pathway. These findings suggest potential…
Cannabinoids and Their Potential in Inflammatory and Metabolic Conditions
Cannabinoids inflammatory metabolic conditions research shows promise but requires cautious interpretation. Clinical efficacy in patient care remains uncertain without robust data. This article highlights the need for skepticism and further studies.
Georgia House Passes Limited Medical Cannabis Expansion! – Blog
Georgia medical cannabis legislation has recently expanded, marking incremental progress in patient access. This legislation affects physicians and patients by broadening therapeutic options. Clinicians should monitor regulatory updates to understand the…
Georgia House Passes Bill to Expand Medical Cannabis Program
Georgia medical cannabis expansion will increase patient eligibility and require clinicians to update screening and dosing protocols. The new bill reflects evidence-based policy development. Providers should prepare for changes in clinical practice and…
Teenagers Have Easy Access to Cannabis. Science Says It’s Bad for Them.
Emerging teen cannabis use and mental health clinical evidence links even occasional use to cognitive impairment and psychiatric risks. Adolescents' developing brains are vulnerable to cannabis's neurotoxic effects. Clinicians should screen and counsel…
Understanding the Dangers of K2 Synthetic Marijuana Today
Synthetic cannabinoid safety concerns are critical for clinicians to understand due to the unpredictable potency and severe health risks of K2. These compounds cause more severe acute effects than natural cannabis, including psychosis and seizures.…
Tennessee: Medical Cannabis Could Be on the Ballot! – Blog
Tennessee medical cannabis legislation is advancing, potentially expanding patient access and prescribing options. This development is crucial for clinicians preparing for new regulations. Understanding this legislation helps healthcare providers support…
